Not Rated
Fund Size
(0.22% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 23-Sep-25 | 9668.40 | -3.32% | - | -2.53% | 198/237 |
1 Month | 29-Aug-25 | 9854.50 | -1.46% | - | 1.11% | 207/236 |
3 Month | 30-Jun-25 | 9937.70 | -0.62% | - | -1.75% | 72/227 |
6 Month | 28-Mar-25 | 10597.70 | 5.98% | - | 8.66% | 150/223 |
YTD | 01-Jan-25 | 9677.30 | -3.23% | - | 0.65% | 143/212 |
1 Year | 30-Sep-24 | 9811.20 | -1.89% | -1.89% | -5.21% | 51/193 |
2 Year | 29-Sep-23 | 15307.30 | 53.07% | 23.65% | 17.41% | 18/149 |
3 Year | 30-Sep-22 | 18941.90 | 89.42% | 23.71% | 19.02% | 24/126 |
5 Year | 30-Sep-20 | 21897.90 | 118.98% | 16.96% | 22.25% | 81/101 |
10 Year | 30-Sep-15 | 28431.80 | 184.32% | 11.01% | 14.10% | 68/75 |
Since Inception | 16-Sep-99 | 339935.90 | 3299.36% | 14.49% | 11.31% | 86/212 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 30-Sep-24 | 12000 | 12217.49 | 1.81 % | 3.36 % |
2 Year | 29-Sep-23 | 24000 | 27864.98 | 16.1 % | 15.03 % |
3 Year | 30-Sep-22 | 36000 | 49993.27 | 38.87 % | 22.48 % |
5 Year | 30-Sep-20 | 60000 | 95499.66 | 59.17 % | 18.63 % |
10 Year | 30-Sep-15 | 120000 | 289641.09 | 141.37 % | 16.78 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 1054 | 9.42% | -0.42% | 11.88% (Apr 2025) | 9.42% (Aug 2025) | 6.61 L | 0.00 |
Cipla Ltd. | Pharmaceuticals | 635.8 | 5.68% | 0.25% | 6.2% (Sep 2024) | 5.43% (Jul 2025) | 4.00 L | 0.00 |
Ajanta Pharma Limited | Pharmaceuticals | 601.3 | 5.38% | 0.58% | 5.38% (Aug 2025) | 4.09% (May 2025) | 2.43 L | 42.67 k |
Lupin Ltd. | Pharmaceuticals | 511.6 | 4.57% | 0.28% | 4.57% (Aug 2025) | 0% (Sep 2024) | 2.70 L | 15.00 k |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 453.6 | 4.06% | 0.07% | 5.28% (Dec 2024) | 3.99% (Jul 2025) | 3.60 L | 0.00 |
Procter & Gamble Health Ltd. | Pharmaceuticals | 446.2 | 3.99% | -0.14% | 4.34% (May 2025) | 3.14% (Dec 2024) | 70.04 k | -0.10 L |
Fortis Healthcare Ltd. | Hospital | 423.9 | 3.79% | 0.31% | 3.79% (Aug 2025) | 3.07% (Apr 2025) | 4.65 L | 0.00 |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 423.3 | 3.78% | 0.24% | 4.07% (Mar 2025) | 3.49% (Sep 2024) | 2.20 L | 30.00 k |
Apollo Hospitals Enterprises Ltd. | Hospital | 403.3 | 3.61% | 0.14% | 3.88% (Sep 2024) | 3.22% (Feb 2025) | 53.00 k | 0.00 |
Alkem Laboratories Ltd. | Pharmaceuticals | 381.9 | 3.41% | 1.00% | 3.41% (Aug 2025) | 1.92% (May 2025) | 72.00 k | 17.00 k |
Name | Type of Instrument | Weight (%) |
---|---|---|
Net Receivables | Net Receivables | 0.64% |
Margin | Margin | 0.01% |
Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 389.09 | 7.68 | 23.98 | 68.86 | 45.59 | 37.55 |
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 249.75 | 2.83 | 10.46 | 22.12 | 26.05 | 20.21 |
Nippon India US Equity Opportunities Fund - Growth | NA | 713.51 | 1.87 | 4.25 | 12.16 | 15.86 | 22.48 |
Nippon India Japan Equity Fund - Growth | NA | 283.56 | 1.59 | 8.27 | 19.74 | 13.00 | 19.41 |
Franklin Asian Equity Fund - Growth | NA | 259.99 | 4.90 | 8.94 | 19.32 | 11.64 | 14.50 |
SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8370.76 | 3.21 | -1.22 | 12.86 | 9.76 | 19.63 |
Motilal Oswal Business Cycle Fund - Regular Plan - Growth | NA | 1976.19 | -3.14 | -1.63 | 8.60 | 7.54 | 0.00 |
DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1331.23 | 3.66 | -1.67 | 10.50 | 6.95 | 0.00 |
ICICI Prudential US Bluechip Equity Fund - Growth | NA | 3356.51 | 0.09 | 5.87 | 14.71 | 6.46 | 19.97 |
HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1533.43 | 2.03 | 12.17 | 31.33 | 5.87 | 0.00 |
Out of 96 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 5 is/are ranked 4 * , 14 is/are ranked 3 * , 8 is/are ranked 2 * , 1 is/are ranked 1 * , and 62 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
UTI Nifty 50 ETF | 5 | 62668.75 | 0.87 | -2.42 | 8.10 | -2.55 | 14.48 |
UTI Nifty 50 ETF | 5 | 62668.75 | 0.87 | -2.42 | 8.10 | -2.55 | 14.48 |
UTI BSE Sensex ETF | 5 | 49128.16 | 0.78 | -2.95 | 7.45 | -2.78 | 13.45 |
UTI BSE Sensex ETF | 5 | 49128.16 | 0.78 | -2.95 | 7.45 | -2.78 | 13.45 |
UTI Flexi Cap Fund - Growth | 2 | 25508.98 | -1.36 | -2.18 | 8.96 | -4.08 | 10.48 |
UTI Liquid Fund - Regular Plan - Growth | 2 | 25036.71 | 0.48 | 1.43 | 3.12 | 6.82 | 7.01 |
UTI Nifty 50 Index Fund - Growth | 3 | 23718.66 | 0.84 | -2.48 | 7.96 | -2.79 | 14.15 |
UTI Nifty 50 Index Fund - Growth | 3 | 23718.66 | 0.88 | -2.41 | 8.12 | -2.52 | 14.54 |
UTI Money Market Fund - Regular Plan - Growth | 3 | 20513.42 | 0.51 | 1.50 | 3.80 | 7.80 | 7.60 |
UTI Large Cap Fund - Growth | 2 | 12948.36 | 0.25 | -2.02 | 7.69 | -4.32 | 12.75 |